bendamustine

AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Yahoo
Fri, 11/13/15 - 10:59 am
AbbVie
Imbruvica
bendamustine
rituximab
chronic lymphocytic leukemia
FDA